GT Apeiron Therapeutics Company

GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.

Estimated Revenue: $1M to $10M
Headquarters: Shanghai, Shanghai, China
Total Funding: 27000000.0
Last Funding Date: 2019-06-11
Investors Number: 1.0
Founded Date: 2019-01-01
Technology: Biotechnology, Health Care, Therapeutics
Industry: Early Drug Development
Last Funding Type: Venture - Series Unknown
Employee Number: 11-50